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 Carbohydrates play significant roles in various biological and pathological 
processes such as cancer metastasis and inflammation. They participate in various 
signaling pathways and are able to bind to a litany of biological receptors such as 
proteins and viruses. Biologists have known for decades that the structures of glycans 
change with the onset of cancer and inflammation. Due to these important activities, 
carbohydrate sensing has long been a focus of research. One example of such a 
carbohydrate sensor is boronic acid-based sensors. Boronic acid-based sensors are of 
particular interest due to their selectivity for 1,2- or 1,3-diols. A variety of techniques 
have been employed for detection. Two techniques that have rarely been applied are 
high-throughput microarray analysis and FRET detection. In this thesis, we present 
work based on the development of a boronic acid-based carbohydrate sensor that will 
be used for microarray analysis and the development of various fluorophore-tagged 
boronic acids as donor/acceptor pairs for FRET detection. Herein, we describe the 
design and development of these compounds as well as initial results in their application 
for the detection of saccharides involved in important biological properties.  
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Chapter 1:  Design, Synthesis and Studies of Boronic Acid 
Based Carbohydrate Receptors 
1.1  Background and Significance of Carbohydrates in Biological 
Processes 
 
Carbohydrates, also known as saccharides, glycans or sugars, play numerous 
roles in living organisms. The carbohydrates are divided into four groups: 
monosaccharides, disaccharides, oligosaccharides, and polysaccharides. In general, 
monosaccharides and disaccharides are simple carbohydrates with low molecular 
weight, which are commonly referred to as sugars. Monosaccharides are the simplest 
and most basic units of carbohydrates; two units of monosaccharides condense to form 
a disaccharide. Even though the nature of carbohydrate nomenclature is complex, the 
names of these simple sugars very often end in the suffix –ose. For example, blood 
sugar is the monosaccharide glucose, table sugar is the disaccharide sucrose, and milk 
sugar is the disaccharide lactose. Oligosaccharides are polymers of sugars containing 
typically two to ten units of monosaccharides. In mammalian systems, they are 
generally found O- or N-linked to compatible amino acid side chains.1 Polysaccharides 
are long carbohydrate chains of repeated monosaccharide units joined together by 
glycosidic bonds. Polysaccharides contain at least ten monosaccharide units and can 
be branched or linear chains. They are used in the storage of energy in the form of 
starch in plants and in the form of glycogen in animals and fungi. In addition, 
polysaccharides act as structural components in plants as cellulose and in arthropods 









In living cells, most membrane-associated and secreted proteins contain 
appended carbohydrate structures, existing as glycoconjugates of different molecular 
configurations such as glycoproteins, glycosaminoglycans, and proteoglycans.3 When 
cells are healthy, these various structures play important roles in molecular recognition 
at fertilization,4,5 cell–cell interactions6, protein degradation, and most crucially, in cell 
signaling.7 However, in tumor cells, some of these glycans tend to be over-, under-, or 
newly expressed and these alterations can often make the tumor cells grow, divide and 
metastasize differently.3 This phenomenon was first discovered by Meezan et al. in 
1969 where they showed that there is a marked decrease of membrane sugars, 
especially sialic acid and N-acetylgalactosamine, following SV-40 virus transformation.8 
This abnormal expression in glycosylation is found in cancer9,10, retrovirus infection,11,12  
and other diseases13. Another feature of tumor cells is the aberrant production of certain 
glycolipids and glycoproteins. In epithelial tumors, mucin glycoproteins, which contain 
dense clusters of O-linked glycans, are often overproduced. As such, mucins are used 
as diagnostic markers of cancer and can serve as scaffolds for most of the cancer-
associated glycans shown in Figure 1.1.14 In addition, cancer cells can overexpress 
gangliosides, which are glycosphingolipid-containing sialic acids. For example, complex 
gangliosides such as GD2, GD3, and fucosyl GM1, as shown in Figure 1.1, are shown 
to be overproduced in small-cell lung carcinomas, neuroblasts and melanomas.15 
Although it is apparent that tumor cells have aberrant glycosylation, there is no one 








 Ovary Pancreas Blood Breast Colon Brain Prostate Skin Lung 
sLex  X  X X    X 
sLea  X  X X    X 
sTn X X  X X  X  X 
TF X   X X  X   
Ley X X  X X  X  X 
Globo H X X  X X  X  X 
PSA  X X X  X   X 
GD2   X   X  X  
GD3      X  X  
Fucosyl 
GM1 
        X 





Each type of cancer tissue is defined by a set of variation in glycan expression as 
shown in Table 1.1. For example, sialyl Lewis X (sLex) is associated with the metastasis 
of B16 melanoma cancer;18 carbohydrate ligand binding to E-selectin controls the 
extravasation of cancer cells and organ selectivity of metastasis;19 sialyl Lewis a (sLea) 
binding to selectin and is involved in the extravasation of human colorectal carcinoma 
cells;20 endothelial cell adhesion, often controlled by carbohydrate–selectin binding, is 
correlated with cancer metastasis;21 and the presence of sLea on cancer cells is 
correlated with risk of cancer metastasis.22 This occurrence is medically significant as it 
highlights opportunities for therapeutic and diagnostic approaches23. 
As discussed above, glycans tend to be over-, under-, or newly expressed in 
tumor cells. These changes often arise due to the altered glycosyltransferase levels in 
cancerous cells, which modifies the core structure of N-linked and O-linked glycans. 
Glycosyltransferases, enzymes that form the glycosidic bonds between sugar units, 
produce an increased enzyme level that often results in an increase in the size and 
brancing of N-linked glycans that in turn cause an increase in global sialylation.24 In 
addition to changes in the glycan core structure, modifications of the terminal structures 
are also linked to diseases. In tumor cells, glycosyltransferases involved in linking 
terminating residues on glycans are more active leading to overexpression of certain 
terminal glycans. Common examples of these terminal glycan epitopes displayed on 
malignant cells are sialyl Lewis X (sLex), sialyl Tn (sTn), Globo H, Lewis Y (Ley) and 
polysialic acid (PSA)10,15a,25 as shown in Figure 1.1. These glycans are present in 
malignant tissues in the brain, breast, colon, and prostate etc. as shown in Table 1.1.26 
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A vital technique in the detection of these glycoproteins in diagnostics is the 
immunoassay for carcinoembryonic antigen (CEA). CEA, a tumor-associated mucin 
antigen, was first described as a colon cancer marker in 1965 by Gold and Freedman.27 
When isolated, CEA is a glycoprotein consisting of ~60% carbohydrate and a molecular 
mass of ~180–200 kDa.28 Most of the carbohydrate is composed of mannose, galactose, 
N-acetylglucosamine, fucose, and sialic acid.28 CEA levels in mammalian systems are 
helpful in monitoring response to treatment and in determining whether there is 
possibility of relapse. The CEA test monitors serum levels of an antibody specific for a 
cancer-associated glycan, sLea.29 In addition to colon cancer, it is also used as a marker 
for other forms of cancer, including cancers of the rectum, lung, breast, liver, pancreas, 
stomach, and ovary. Elevated levels of CEA in the blood exhibit a strong, positive 
correlation with an increased risk of relapse and metastasis. The CEA test is used to 
monitor CEA levels in colon cancer patients, and although it has proven to be valuable, 
tests like these have their drawbacks because they are unstable towards rigorous use, 
expensive, and difficult to produce. Other serum markers, such as CA12530 and 
prostate-specific antigen,31 reveal aberrant glycosylation in ovarian and prostate tumor 
tissues. However, for many cancers, there are no serum markers and the tissues must 
be analyzed directly. Existing methods requires surgical biopsy of tumor tissue followed 
by histological analysis with lectins and monoclonal antibodies. Hence, viable 
alternatives for detection of glycans are being actively pursued.32  
An interesting future direction to detect aberrant glycosylation is by using probes 
for image contrast.33 As mentioned above, mucin glycoproteins are overproduced in 
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epithelial tumors. Specifically, underglycosylated MUC1 antigen (uMUC1) is highly 
overexpressed in various human epithelial cell adenocarcinomas and is an early marker 
of tumorigenesis.34 The protein portion of uMUC1 can be recognized by a specific 
peptide (termed EPPT1) derived from a monoclonal antibody.35 Epenetos and co-
workers developed an EPPT1 based probe that is capable of monitoring breast cancer 
in vivo.35b More recently, Dai and co-workers synthesized an EPPT1 conjugate that can 
be used for magnetic resonance and optical imaging.36 Experiments with this new probe 
showed promising results as positive tumor models showed accumulation of probe in 
the tumor tissues while there was very low signal in uMUC-1-negative tumors. However, 
uMUC1-specific imaging targets the underglycosylated protein, not the carbohydrate 
directly.  
This thesis describes work towards developing a method that would allow for 
effective detection of glycans. Boronic acids are known for forming strong, reversible, 
covalent bonds with 1,2 and 1,3 cis-diols on many sugar molecules.37 These boronic 
acids-based lectin mimics are cheap, easy to synthesize and stable towards rigorous 
use. Hence, we believe that they can be used as lectin mimics to detect aberrant 
glycosylation in a small molecule microarray, which will be discussed in further detail in 
Section 1.3.  
1.2  Types of Receptors and Sensors for Saccharide Binding  
Receptors and sensors for carbohydrate binding can be classified into four 
categories: (1) antibodies,38 (2) lectins,39 (3) aptamers based on nucleic acids,40 and (4) 
small molecule lectin mimics.41 Antibodies are traditionally used in the recognition of a 
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litany of analytes including carbohydrates. However, they are not used in large-scale 
arrays due to cost and stability. Currently, lectins are the most available tools used in 
research for carbohydrate recognition but they often have issues with cross-reactivity.42 
Hence, it is important to develop new alternatives that possess: (1) high affinity, (2) high 
specificity, and (3) are suitable for high throughput analysis. This allows for accurate 
and precise study of carbohydrate changes at the glycome level. In order to fulfill these 
requirements, there have been major recent developments in fluorescent sensing 
methods for carbohydrates for a variety of applications. To this end, small-molecules 
and “polymeric binders” have been actively developed. One significant example is the 
use of boronic acid-based carbohydrate sensors, such as boronolectin, which is a 
specific term for peptides containing boronic acids. There are small molecule 
boronolectins (SBL), peptidoboronolectins (PBL), and nucleic acid-based boronolectins 
(NBL).  
The first phenylboronic acid (PBA) was synthesized by Michaelis and Becker in 
1880.43 However, it was 74 years before scientists discovered the ability of boronic and 
boric acid to bind with diols. Later publications detailed the studies of a variety of diols 
and their binding interactions with boronic and boric acid44,45. In 1954, Kuivila and his 
co-workers noticed that polyols and saccharides were soluble in boronic acid solutions, 
and they suggested the formation of a cyclic ester.46 This result agreed with the known 
ability of borates to interact with hydroxyl compounds. It was in 1959 that Lorand and 
Edwards reported the first quantitative study of the binding constants between several 
compounds containing diols and PBA.47  
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Boronic acids have been known to form strong and yet reversible covalent bonds 
with 1,2- and 1,3-substituted Lewis base donors such as hydroxyl, amino, and 
carboxylate groups. This interaction with diol or alcohols results in boronic esters 
(neutral trigonal boron) or boronate esters (anionic tetrahedral boron) based on the 
oxidation state of the central boron atom. All these properties have been studied and 
explored extensively in research as it allows for boronic acid compounds to be used as 
lectin mimics, as nucleotide and carbohydrate transporters, and as affinity ligands for 
the separation of carbohydrates and glycoproteins.48 As shown in Figure 1.2, the 
boronic acid (1) has an empty boron orbital that allows for reaction with a protic solvent 
to form an anionic tetrahedral boronate (2) with the release of a proton. Upon reaction 
with the diol moiety, the boronic acid is converted into a boronic ester (3), which is 
similar to boronic acid because it can react with a water molecule, release a proton, and 
become a boronate ester (4). The equilibria for the formation of the anionic boronate 
complex is defined as Ktet, and the formation of a boronic acid complex is defined as 









Figure 1.3.  Overall binding of phenylboronic acid with a diol 
 
 
Figure 1.4.  Equilibria for ortho-aminomethylphenylboronic acids 
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The binding of boronic acids to diols can be interpreted one of two ways. One 
way is to look at individual chemical reactions and the binding between the trigonal 
boronic acid and the diol or the binding between the tetrahedral boronate and the diol as 
shown in Figure 1.2. In this case, Ktrig represents the binding constant between the 
trigonal boronic acid and the boronate ester; and Ktet shows the equilibria between the 
tetrahedral boronate and the boronate ester anion. The binding of boronic acids can 
also be described in Figure 1.3, which shows the overall binding equilibria instead of the 
individual reactions. In this case, Keq is used to describe the overall binding constant, 
which is an apparent binding constant but is directly relevant to the equilibrium between 
a sensor and a carbohydrate.  
 In order to develop a practical boronic acid-based carbohydrate sensor, it is vital 
that binding can occur at physiological pH. However, since the reported pKa of 
phenylboronic acid is 8.8, a design to lower the pKa of boronic acid is necessary for 
strong binding to occur. B–N bond formation, when functionalized in a relative 1,5 
position, acts as a special boronic acid-based sensor, as was shown by the work of 
Wulff49 and Shinkai.50 Wang and co-workers have studied in detail how the B–N bond 
changes in character as it forms complexes with carbohydrates.51 These results were 
further supported by structural work from the Anslyn lab.52 A method, developed by 
Wulff, used a neighboring aminomethyl group as shown in Figure 1.4. The pKa for the 
second stepwise protonation in water of ortho-aminomethylphenylboronic acids was 




Figure 1.5.  Mechanism of sugar sensing by the viologen–boronic acid system. 
 
 
Figure 1.6.  Dye displacement reaction of the adducts between boronic acid 
derivatives and Alizarin Red S (ARS) for glucose sensing. 
 Since boronic acids are able to react with diols and single hydroxyl groups, they 
are the most commonly used moieties for the construction of binders for carbohydrates, 
which contain many hydroxyl groups. One of the most common techniques employed is 
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the use of fluorescent sensors. An example of a small molecule boronic acid sensor for 
saccharide is the viologen bisboronic acid system developed by Singaram and co-
workers.55 The system uses anionic fluorescent dyes in combination with boronic acid 
as a chromophore and a recognition unit. Viologen is a dye that is considered to be 
electron deficient and redox sensitive. A mixture of substituted viologen boronic acid 
and fluorescent anionic dye solution results in a nonfluorescent complex due to stacking 
and quenching presumably due to charge transfer.55b Once bound to a sugar, the 
boronic acid moieties are converted to their anionic form, which combined with the 
bulkiness of the molecule results in dissociation of the nonfluorescent complex and 
triggers an increase in fluorescence intensity as shown in Figure 1.5. The sensitivity of 
the system can be adjusted by modifying the ratio of the anionic dye 8-hydroxypyrene-
1,3,6-trisulfonic acid trisodium salt (HPTS) and the boronic acid-substituted benzyl 
viologens (BBV) recognition unit.  
 Another example of fluorescent sensors is the use of alizarin and its 
derivatives.56 A displacement of binding between boronic acid derivatives and diols 
containing fluorescence dyes such as alizarin or Alizarin Red S (ARS) by a target 
saccharide as shown in Figure 1.6, which has been used to develop new sensors.57 
Alizarin and their derivatives normally provide a very weak emission and their 
fluorescence intensities are turned on when forming adducts with boronic acids. When 
diol-containing compounds are added into the alizarin-boronic acid mixture, the alizarin 
derivatives are displaced and the fluorescence signals are turned off. The decreasing 
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degree of fluorescence intensity depends on the concentration of the diol-containing 
compounds added.  
Recently, there has been more interest in the design of nanoparticulate materials 
since they were found to have several advantages owing to their small size and high 
surface-to-volume ratio.58 Larpent and co-workers developed a system of boronic acid-
functionalized nanoparticles for use as a re-usable optical nanosensor for 
carbohydrates.59 It is believed that boronic acid-functionalized nanoparticles can 
possibly provide valuable supports for the optical detection, the transport, or the 
separation of carbohydrates. They reported on the synthesis of boronic acid 
functionalized nanoparticles and the study of their diol binding capacity. The catechol, 
ARS, and the boronic acid-functionalized nanoparticles afford an optical colored 
nanosensor. This nanosensor is then used for fructose binding and detection in a 
competitive assay. As mentioned earlier in the section, the binding of sugar is 
evidenced by a color change. The boronic acid functionalized nanoparticles are formed 
by reacting 3-aminophenylboronic acid (APBA) with NL-CH2X at room temperature, as 
shown in Figure 1.7. The nanosensor allows the visual detection of fructose as shown in 
Figure 1.8. The binding of fructose to boronic acid-functionalized nanoparticles is easily 
observed by the color change of NL–B(OH)2–ARS mixture from orange to burgundy due 
to released ARS. When titrations were performed with increasing concentrations of 
fructose, it was evident that the ARS was being displaced with fructose due to the 
absorbance change. However, when the same titration was performed with glucose, it 
does not perturb the ARS-supported boronic acid equilibrium even at high 
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concentrations. Due to this interesting phenomenon, Lapert and co-workers went on to 
discover applications for the boronic acid-functionalized nanoparticles as it allows for 
selective separation of fructose from mixtures.  
 
Figure 1.7.  Preparation of boronic acid-funtionalized nanoparticles        
 
Figure 1.8. Competitive assay: binding of the dye (ARS) and dissociation in the 




1.3  Microarray Analysis of Binding between Boronic Acids and 
Glycoproteins 
Over the past two decades, microarray analysis has transformed the life science 
research landscape. Microarray is a technique that can screen multiple reagents 
simultaneously with minimal consumption of sample. Essentially, it is a multiplex lab-on-
a-chip. An example of a scanned microarray slide with a fluorescence intensity gradient 
is shown in Figure 1.9. The technology itself was first used in DNA assemblies on chips, 
but shortly thereafter, it was possible for researchers to sequester small molecules60 
and then proteins61 for rapid analysis. By now, microarray technology has progressed to 
the point where we can examine a host of other biomolecules, including membrane 
proteins,62 carbohydrates,63,64 and peptides,65 as well as complex structures such 
tissues66 and even live cells67 on arrays. It is noteworthy how a single technology 
platform has developed for so many diverse applications. In comparison to microtiter-
based assays, microarrays are high-throughput and offer a flat surface for the washing 
and incubation steps.  This design concept makes it possible to process thousands of 
assays quickly and in a less costly manner by reducing the amount of expensive 




Figure 1.9.  Image of scanned microarray glass slide with fluorescence intensity 
gradient 
 
Microarrays can be classified into two general types, biochips (biomicroarray) 
and chemical microarray (small molecule microarray).68 Biochips are arrays of biological 
components, such as protein, DNA, cell, and tissue. Chemical microarrays are arrays of 
organic compounds including small organic molecules, peptides, and sugars. In 1999, 
MacBeath and Schreiber published the first small molecule microarray research. They 
immobilized thiolated compounds onto maleimide-derivatized slides through a thioether 
bond and screened them against a series of model proteins.60 Chemical microarrays 
have a wide variety of applications, ranging from drug and biomarker discovery to 
disease detection and profiling.69 For example, chemical microarrays are used in 
modern drug discovery research to study the interaction between small molecules and 
biological targets.70 Figure 1.6 shows the interaction of amino-modified DNA with an 




Figure 1.10. Immobilization chemistry of primary amine to epoxysilane glass slides 
 
As compared to DNA and protein microarrays, the development of chemical 
microarrays has progressed more slowly.71 One reason for this is that, unlike certain 
biomicroarrays, there is no general linking technology that can be applied to immobilize 
different compounds containing different functional groups on the same glass slide. A 
litany of strategies has been developed to fabricate chemical microarrays. For example, 
stable carbohydrate microarrays can be fabricated using Michael addition,72 Diels–Alder 
reaction,73 Staudinger ligation,74 click chemistry,75 Schiff base formation,76,77 and amide 
bond formation.78,79 The detection methods for microarray has matured and extended 
beyond fluorescent labels, to include label-free optical impedance measurements,80 
surface plasmon resonance81 and mass spectrometry-based techniques.82 Lin and co-
workers developed a novel and straightforward carbohydrate microarray through 
boronate formation.83 Boronic acid forms a stable but reversible complex with cis 1,2- or 
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1,3- diols of carbohydrate, and this allows it to be used as a glycol-targeting probe in 
numerous applications.48a, 48f, 84 They reported the use of an aldehyde-functionalized 
slide that was reacted in solution to produce a boronic acid-functionalized slide that 
would provide a simple and straightforward way of attachment of a litany of unmodified 
carbohydrates onto the slide surface. The carbohydrates were then probed with biotin-
labelled lectins or antibodies and then detected by Cy3-streptavidin or Cy3-conjugated 
secondary antibodies. 3-Aminophenyl boronic acid (APBA), a cheap and readily 
available boronic acid was selected to implement the carbohydrate microarray. This 
developed method is suitable for all sizes of carbohydrates besides monosaccharides. 
The reason is that the hydroxyl groups involved in lectin recognition could be occupied 
by the boronic acid. This method is highly convenient as it circumvents the modification 
of sugar molecule before immobilization which is often tedious and time consuming. 
Another notable strategy in glycomics, i.e. the high throughput analysis of 
carbohydrates, is the use of lectin microarrays.85 Lectin microarrays are a form of 
protein microarray that utilizes glycan-binding proteins that have proven to be very 
effective for the high-throughput analysis of glycans.86 However, the majority of lectins 
being used are proteins isolated from plants. These plant lectins are isolated and 
purified from natural resources, which often result in inconsistent activity and availability 
due to differences in purification and seasonal changes. In addition, most plant lectins 
exist as glycoproteins so the lectins themselves could serve as receptors for 
carbohydrate-binding proteins leading to false positives. To resolve these issues, Mahal 
and co-workers set out to create a recombinant lectin with bacterially- derived lectins for 
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use in microarray technology.85 They cloned, expressed and purified a small panel of 
lectins as N-terminal GST–His6 fusions with no noticeable effects on specificity and 
provided the possibility of an oriented microarray. In microarray analysis, the simple 
lectin panel was able to distinguish between both glycoprotein samples and cell lines, 
supporting the idea that a broader lectin panel may be useful for both diagnostics and 
carbohydrate analysis. This technology is highly efficient as it allows for rapid 
assessment of carbohydrates using minimal sample amounts (<1 μg).86 By 
standardizing the conditions for cloning, expression, and purification of bacterial lectins, 
it is possible for us to create a large, well-defined lectin library for the rapid analysis of 
complex carbohydrates. 
1.4 FRET-Based Detection 
In addition to microarray technology, detection using Förster Resonance Energy 
Transfer (FRET) is also often used the study of carbohydrates. In order to characterize 
and detect the density of glycosylated surfaces, an efficient method is needed that 
offers high resolution in identifying clusters of dense glycans on cell surfaces. This is 
useful in lipid rafts because cell membranes have regions that are concentrated with 
specific components, such as sphingolipids, that result in areas of dense 
glycosylation.87 These regions have high signaling activity in cells, and it is important 
that they be characterized. To this end, we designed carbohydrate binding boronic acid 
receptors derivatized with FRET.88  
FRET is commonly applied in biology and chemistry and has been used to 
measure distance and detect molecular interactions in a number of systems. In this 
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sense, FRET has been used to provide information about protein conformation because 
it measures distances between domains in a single protein.89 Applied in vivo in living 
cells, FRET has given us the opportunity to explore the location and interactions of 
genes and cellular structure such as integrins and membrane proteins by using variation 
of the Green Fluorescence Protein (GFP).90 In addition, FRET can be used to obtain 
information of crucial biological pathways and is also used to study lipid rafts in cell 
membranes.91 
FRET describes the energy transfer between two fluorophores. This mechanism 
was first discovered by the German scientist Theodor Förster in 1948.92 When 
employing FRET, a donor and an acceptor are involved. When a donor fluorophore is 
excited, it transfers energy to an acceptor in close proximity, and this allows for the 
transfer of energy through nonradiative dipole–dipole coupling as shown in Figure 1.11. 
When choosing FRET pairs, it is a requirement that the emission spectrum of the donor 
overlaps with the absorption/ emission spectrum of the acceptor. FRET can be an 
accurate measurement of proximity at very short distances (10–100 Å) and highly 
efficient if the donor and acceptor are within the Förster radius, which is typically 3–6 
nm.93 The technique itself is very sensitive and provides high resolution because the 
rate of energy transfer of FRET is dependent on the inverse sixth power of the distance 
between the donor and acceptor. Thus, in domains of dense glycosylation, we would 
observe an increase in acceptor emission and decrease of donor emission.94 In areas of 
sparse glycoslyation, there should be little to no background acceptor emission. Hence, 
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we expect to detect regions of heavy glycoslyation with high resolution by using this 
FRET-based assay.  
 




Chapter 2:  Design and Synthesis of a Boronic Acid Lectin 
Mimic to study Carbohydrate Binding using 
Microarray Analysis and FRET 
 
2.1 High-throughput Microarray Analysis 
2.1.1 Research Design 
In pursuing a boronic acid-based carbohydrate sensor, compound 2.3 (Figure 
2.4), that is effective for microarray analysis, certain characteristics had to be 
incorporated. First, the final compound must have a terminal amine to cleave open the 
epoxides on the microarray glass slide to allow for attachment to the glass surface. Next, 
a phenylboronic acid is needed to facilitate binding to polyol compounds. An ethylene 
diamine linker was included to extend the distance between the boronic acid and the 
terminal amine. The aminomethyl group attached to the phenylboronic acid lowers the 
pKa of the phenylboronic acid and allows for better binding at physiological pH.
49a  
Three different polyol compounds with fluorescent capabilities were selected for 
microarray analysis with boronic acid-based sensors: alizarin, tetramethylrhodamine 
tagged avidin, and mucin. Alizarin, or 1,2-dihydroxyanthraquinone, was used as a 
model to detect binding between catechols and boronic acids as catechols are known to 
have higher binding affinities as compared to sugars.95 Upon binding with boronic acid 
moieties, alizarin becomes fluorescent as shown in Figure 2.1 and allows for direct 
detection of fluorescence.96 Alizarin is an efficient model as it is cheap and commercially 
available. The microarray analysis results provided us with a range of concentrations of 
boronic acid-based sensors where we believe the fluorescence intensity to be 
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representative of binding between the sensor and catechol. Glycoproteins such as 
avidin and mucin were chosen to detect binding between sugars and boronic acids. 
Binding of avidin and mucin to slide surfaces for detection are shown in Figure 2.2 and 
2.3. Glycoproteins were selected instead of simple sugars because they offer the option 
of multivalent binding sites. Generally, a glycoprotein contains many glycan chains and 
numerous kinds of carbohydrates. For example, Mucin1 (MUC1) is a glycoprotein with 
extensive O-linked glycosylation of its extracellular domain and contains sialic acid.14 
Hence, the boronic acid-based sensor on the slide surface would have multiple 
opportunities to detect the glycoprotein.   
 




Figure 2.2. Binding of alizarin and avidin to microarray slide surface 
 
Following the recognition of alizarin, we explored the detection of 
tetramethylrhodamine-tagged avidin. This is essential as it gave us an opportunity to 
directly investigate the binding of the glycoprotein with the boronic acid-based sensor as 
shown in Figure 2.2. However, fluorophore-tagged glycoproteins do not exist in nature 
and to accurately depict the binding of glycoprotein with our boronic acid-based sensor, 
we selected mucin1 for microarray analysis. Mucins line the epithelial cells in the lungs, 
stomach, intestines, eyes and several other organs.34b Overexpression of MUC1 is often 
associated with colon, breat, ovarian, lung and pancreatic cancers.97 Upon printing the 
boronic acid-based sensor on the microarray slide surface, we incubated the supergrids 
with the mucin1 glycoprotein. Unlike the tetramethylrhodamine-tagged avidin, mucin1 is 
not fluorescent and antibodies are needed for detection. As shown in Figure 2.3, the 
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primary antibody, MUC1 antibody, and secondary antibody, Cy3-tagged goat-anti-rabbit 
antibody, binds to the MUC1 glycoprotein and the fluorescence is then detected to 
affirm binding.  
 
 
Figure 2.3. Binding of mucin1 to microarray slide surface followed by tagging with 






2.1.2 Research Synthesis of Compound 2.3 
The final synthetic route to construct compound 2.3 is shown in Figure 2.4. It 
begins with the mono-Boc protection of commercially available ethane 1,2-diamine to 
produce compound 2.1. The free amine is then coupled to 2-formylphenylboronic acid 
via a reductive amination to produce compound 2.2. The Boc group was then 
deprotected by using trifluoroacetic acid to yield the trifluoroacetate-ammoium salt 2.3.  
 




2.1.3 Results and Discussions                                                                                                                                                                                                                    
As mentioned above, boronic acids can form a stable but reversible complex with 1,2- 
and 1,3 diols of carbohydrate by formation of a boronate ester in aqueous media at 
room temperature.47 Herein, we describe the utility of microarray analysis for using 
boronic acids as lectin mimics to detect certain carbohydrate structures. Compound 2.3 
was printed onto epoxide-functionalized glass slides purchased from Schott Nexterion®. 
The amine of the ethylene diamine linker cleaves open the epoxides on the glass 
surface to form covalent bonds when immobilized with the basic print buffer (phosphate 
buffered saline (PBS), pH 8.5 and borate buffer, pH 9). On the slide, several supergrids 
are usually printed, and 12 different concentrations of each boronic acid will be on each 
supergrid. This is then followed by washing and blocking of the unreacted slide surface 
and then incubation with the polyol compounds. 
 




Using the SDDC-2 robotic printer from ESI, compound 2.3 was printed onto 
epoxide-functionalized glass slides. The pin on the robot has an uptake volume of 0.25 
μL/ sample channel, a tip size of 75 μm, and a delivery volume of 600 pL. An image of 
the pin and printhead is shown in Figure 2.5. Several different buffers were used when 
spotting. We first attempted to use tris(hydroxymethyl)aminomethane (TRIS) buffer but 
that proved to be ineffective, and we postulated that the buffer contains a free amine 
group that could possibly compete with the boronic acid for reacting with epoxy 
functional groups. Borate buffer at pH 9 and PBS at pH 8.5 were tried out as print 
buffers and both provided reasonable results as shown in Figure 2.6–2.9. After 
overnight incubation, the printed slides were washed thoroughly to remove any unbound 
boronic acid. The slides spotted with borate buffer were washed with borate buffer 
containing 0.05% Tween-20 at pH 9 and the slides spotted with PBS would be washed 
with PBS with 0.05% Tween-20 at pH 8.5.  
To avoid non-specific interaction between the diol moiety and the slide surface, it 
is essential to block the slide surface. Blocking was initially done with ethanolamine 
block buffer, but high fluorescence background was observed. Diethylamine block buffer 
showed better results and was used for subsequent assays. After an hour of blocking, 
the slide was washed thoroughly to remove any traces of block buffer and then dried. 
The slides spotted with borate buffer were incubated in a solution of buffered alizarin in 
methanol, and the slides spotted with PBS were incubated in a solution of alizarin in 
PBS. After alizarin incubation, the slides were washed thoroughly to remove any 
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unbound compound followed by detection of fluorescence by slide scanning. 
   
Figure 2.6 Left: Results of 0–200 μM compound 2.3 printed in 20 mM Borate buffer 
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed 
results of mean fluorescence intensity of each column on the left with error 
bars depicting the standard error. 
   
Figure 2.7 Left: Results of 0–200 μM compound 2.3 printed in 20 mM Borate buffer 
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed 
results of mean fluorescence intensity of each column on the left with error 





























































Figure 2.8 Left: Results of 0–480 μM compound 2.3 printed in 20 mM Borate buffer 
and 20% DMSO and incubated with 0.1 mM alizarin. Right: Graphed 
results of mean fluorescence intensity of each column on the left with error 
bars depicting the standard error. 
 
  
Figure 2.9  Left: Results of 0–1000 μM compound 2.3 printed in 30 mM phosphate 
buffer and 20% DMSO and incubated with 0.1 mM alizarin. Right: 
Graphed results of mean fluorescence intensity of each column on the left 































































Three different compounds with diol moieties were incubated with the boronic 
acid—alizarin, tetramethylrhodamine tagged avidin and mucin 1. Alizarin was used as a 
model for the fabrication of the microarray because catechols are known to have higher 
binding affinities with boronic acids than carbohydrates. Twelve different concentrations 
(0, 10, 20, 30, 40, 50, 60, 80, 100, 120, 160, 200 μM) of each boronic acid in 20 mM 
borate buffer with 20% DMSO were spotted on each supergrid, then blocked and 
incubated with its respective assay. The maximum concentration was initially capped at 
200 μM as a previous study by Lin and co-workers observed plateauing of fluorescence 
intensity when the PBA concentration was at 200 μM. However, our results indicate that 
this maximum concentration does not apply to our assay. 
Incubation with 0.2 mM alizarin in 20 mM borate-buffered methanol showed 
positive linear correlation between fluorescence intensity and concentration of boronic 
acid. The maximum boronic acid concentration used in printing was then increased to 
300 μM, 480 μM, and ultimately to 1000 μM (300 μM and 400 μM were printed with 20 
mM borate buffer at pH 9, and 1000 μM was printed with 30 mM PBS at pH 8.5) in order 
to achieve a plateau in fluorescence intensity. It was with printing up to 1000 μM that 
leveling off in fluorescence intensity was observed. Hence, 12 concentrations (0, 10, 30, 
50, 80, 120, 200, 300, 400, 500, 800, 1000 μM) of boronic acids were chosen to be 
incubated with tetramethylrhodamine tagged avidin and mucin. Preliminary results with 
tagged avidin show that binding between avidin and PBA does occur because 
fluorescence spots were observed.  
2.1.4 Conclusions and Future Work 
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We successfully used microarray techniques to show that binding between 
alizarin and boronic acid occurred on epoxide-functionalized slides. The printing of the 
boronic acid-based sensors proved to be the most challenging step in the microarray 
analysis. Ultimately, printing with 30 mM PBS with 0.05 % Tween at pH 8.5 proved to be 
effective. Blocking of the unreacted slide surface was initially unsuccessful with 
ethanolamine buffer but switching to diethylamine buffer rectified the issue. The slides 
were incubated with alizarin, tetramethylrhodamine-tagged avidin and MUC1 as shown 
in Figures 2.2 and 2.3. The work done with alizarin proved to be successful but the 
incubation of the boronic acid-based sensor with tetramethylrhodamine-tagged avidin 
and MUC1 requires further optimization. 
Preliminary results of microarray analysis with tetramethylrhodamine-tagged 
avidin and MUC1 showed that the supergrids were visible, which is a positive indication 
of binding. However, unlike Figures 2.6–2.9 of the alizarin slides, a gradient of 
increasing fluorescence intensity was not observed. Hence, further optimization of the 
conditions is necessary.  
2.1.4.1 Problems with Printing 
Even though the previously mentioned microarray assays have yielded intital 
results, it could benefit from further optimization. One of the biggest problems we have 
faced with microarray analysis is inconsistency. The printing of samples on the slide 
surface has often proven to be temperamental. Typically, supergrids can be observed  
on the glass surface after printing as the printing buffer is an aqueous solution with high 
salt content. There are many instances where after printing, no visible spots can be 
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seen on the slide. If that is the case, no printing solution has been deposited on the 
slide surface. This could be due to many issues 1) The solution being spotted has 
evaporated before printing could occur, 2) The solution has clogged the pin tip, 3) The 
pin tip could be damaged. The evaporation issue can be addressed by increasing 
humidity of the environment while printing, adding high boiling and/or viscous solvents 
such as dimethyl sulfoxide or glycerol. In addition to having no spots, a frequent 
problem is pin clogging. It appears that during the printing sequence, the pin becomes 
clogged and stops depositing solution on the slide surface as seen in Figure 2.10b. This 
problem can usually be solved by adjusting the concentration of the buffer. For example, 
this phenomenon was a common occurrence when the printing buffer was 50 mM 
borate buffer with 0.05% Tween. Attempts were made to solve this problem by 
sonicating the pin before every print sequence and carefully air drying the pin, but it did 
not improve the printing situation. However, when we tried printing instead with 20 mM 
borate buffer with 0.05% Tween, the pin printed perfectly but the spots were hollow in 
the center. This could potentially cause inaccurate fluorescence readings. We 
postulated that this was because the printed spots were drying out too quickly, so new 
printing solutions with 20% DMSO were prepared to resolve this issue.  At times, the 
spots printed could merge together as shown in Figure 2.10c. When this occurs, a 
simple solution such as adjusting the buffer concentration usually solves this issue.  
Ultimately, if modifying the printing conditions does nothing to improve the 
printing situation, it is possible that the pin is damaged. A convenient way to determine 
whether the pin is damaged is to have it print solutions of printing buffers. If the pin is 
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able to print grids of buffers with no noticeable difficulty (clogging etc.), then further 




a)  b)  c)  
Figure 2.10.  Image of supergrids as viewed under a microscope a) a well printed grid 
where spots appears to be evenly spaced and evenly sized b) a poorly 
printed grid where pin clogging occurs c) a poorly printed grid where spots 
merged together. 
 
2.1.5 Experimental  
Materials  
Epoxysilane-coated glass slides (Nexterion slide E) were purchased from 
SCHOTT North America). Tetramethylrhodamine tagged avidin (Protein Mods), mucin 1, 
mucin 1 antibody and cy3 tagged goat-anti-rabbit antibody were purchased from Novus 
Biologicals; other standard chemicals were purchased from commercial suppliers and 
used as received. Glass slides were stored in a desiccator to keep them dry.  
Methods 
Microarray fabrication 
Stock boronic acid solution was stored at 5 mM in water and kept at -20 oC in a 
freezer. When printing with borate buffer, 12 different concentrations (0, 10, 20, 30, 40, 
50, 60, 80, 100, 120, 160, 200 μM) of boronic acids were prepared in a 96-well plate 
with 0 μM acting as the control. This was also repeated for printing up to 300 μM (0, 18, 
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42, 60, 81, 102, 120, 150, 180, 210, 250, 300 μM ) and 480 μM (0, 9, 24, 39, 60, 81. 99, 
150, 198, 270, 360, 480 μM). Initially, printing was done with 50 mM borate buffer but 
this clogged the pin, so the concentration of the buffer was lowered to 20 mM. However, 
after lowering the concentration of buffer, the spots appeared to be hollow, and that 
caused inaccurate fluorescence reading. We postulated that this was because the 
printed spots were drying out too quickly, so new printing solutions with 20 mM borate 
buffer with 0.05 % Tween at pH 9 and 20% DMSO were prepared. When printing with 
PBS, 12 different concentrations (0, 10, 30, 50, 80, 120, 200, 300, 400, 500, 800, 1000 
μM) of boronic acids in PBS and 0.05% Tween at pH 8.5 were prepared in a 96 well 
plate with 0 μM acting as the control. 
Using the standard robotic pin printer, the different solutions of boronic acids 
were printed on the epoxide-functionalized glass slides, and each super grid was 
printed in a 12 x 10 pattern. After an overnight incubation in a humidifying chamber, 
which is essentially a container holding a piece of hot paper towel, the slides were 
washed by submerging them in Petri dishes filled with wash buffer and gently shaking 
on a waver. The slides printed with borate buffer were washed with borate buffer and 
0.05% Tween at pH 9, and the slides printed in PBS were washed with PBS buffer and 
0.05% Tween at pH 8.5. The slides were washed 3 separate times with their respective 
wash buffer at 5 minute intervals. Blocking was done by gently shaking the slide on a 
shaker for 1 hour with the slide in a Petri dish filled with 20 mM diethylamine in 20 mM 
borate buffer and 0.05% Tween at pH 9. After blocking, the slides were washed three 
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times at 5 minute intervals with their respective wash buffers and then dried with 
nitrogen air and used for incubation. 
Binding Assays 
Alizarin was dissolved in borate-buffered methanol to give a concetration of 0.1 
mM alizarin (borate buffer: 20 mM boric acid, 20 mM sodium borate in methanol at pH 
8.5). During incubation, the glass slide would be submerged in 50 mL of buffered 
alizarin in a Petri dish for 1 hour. The Petri dish was covered to prevent evaporation of 
solvent. The Petri dish used for incubation was left on a flat surface and not placed on a 
waver as preliminary results showed that shaking provided unsuccessful results. After 
incubation was complete, the slides were washed 3 times with their respective wash 
buffer and 3 more times with water. Each wash with wash buffer took approximately 5 
minutes and each wash with water took approximately 15 minutes.  The slides were 
dried completely using nitrogen air and then scanned immediately to obtain results.  
Data Analysis 
Using the GenePix® 4000B microarray scanner from Axon instruments, the 
fluorescence intensities of microspots were quantified. The array reader has a 532 nm 
wavelength laser which scanned the slide and showed the image of the supergrid. The 
spot with no boronic acid was used as the control. The spots which showed anomalous 




2.2  FRET Detection 
2.2.1  Research Design 
In order to characterize and detect the density of glycosylated surfaces, we set 
out to design carbohydrate-binding boronic acid receptors derivatized with FRET pairs 
as shown in Figure 2.11. To achieve this goal, several fluorophore-tagged boronic acids 
were synthesized by my co-workers and me. Coumarin-tagged (synthesized by me) and 
NBD-tagged (synthesized by Chí-Linh Đỗ-Thanh) boronic acids, 2.5 and 2.6 in Figure 
2.12, respectively, were used as a FRET pair because of overlap in emission and 
excitement in donor and acceptor. Compound 2.5 was synthesized via a coupling 
reaction that involved generation of a common boronic acid precursor appended to an 
amine functionality, which can be modified via specific reactions, such as reductive 
amination or coupling, to introduce different fluorophores, which entails modification in 
the final step. Another option would be to couple the amine to the fluorophore first, 
followed by addition of the boronic acid, as that would simplify the purification step. The 
two synthetic routes are shown in Figure 2.13 as 2.13A and 2.13B. 
In addition, two different guests were involved in FRET studies, a catechol 
compound, 2.7 in Figure 2.12, (synthesized by Manpreet Kaur Cheema) and a mannose 
compound, 2.8 in Figure 2.12, (synthesized by Irene Abia). The idea of using divalent 
guests arose because we wanted to create a system that could imitate cell-surface 
carbohydrate clustering involving sugar molecules in the near vicinity. In order to 
activate FRET, the diol moieties on the mannose sugars or catechol derivatives were 
connected via a linker, as shown in Figure 2.11, to bind the donor and acceptor on the 
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same molecule bringing them into closer proximity. As reported in literature,95 the 














2.2.2 Research Synthesis 
 To synthesize the coumarin-tagged boronic acid, compund 2.5 as shown in 
Figure 2.7, two different synthetic routes were pursued as shown in Figure 2.13. The 
synthesis of coumarin-tagged boronic acid receptor 2.5  was initiated via mono-Boc 
protection of ethylenediamine. Afterwards, two different synthetic routes were attempted 
to observe which one was more efficient.  The mono-Boc protected ethylenediamine 
was coupled with 2-formylphenylboronic acid via reductive amination to produce 2.2. 
Boc deprotection of 2.2 using trifluoroacetic acid followed by EDC coupling gave 
compound 2.5. This method provided us with an overall lower yield as purification of the 
polar compound 2.2 proved to be troublesome. Another option was for us to install the 
phenylboronic acid in the last step to make purification easier. The mono-Boc protected 
ethylenediamine was first coupled to coumarin-3-carboxylic acid to give compound 2.4 
by EDC coupling. This was followed by Boc deprotection using trifluoroacetic acid and a 
substitution reaction with 2-bromomethylphenylboronic acid.  
 




Figure 2.13. Synthesis of coumarin-tagged boronic acid receptor via routes 2.13A and 
2.13 B. 
 
Figure 2.14.  Synthesis of pyrene-tagged boronic acid receptor. 
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 Attempts were made to synthesize pyrene-tagged boronic acid receptors for 
FRET detection as shown in Figure 2.14. Pyrene was selected for this purpose as it can 
function as both the donor and the acceptor. Unfortunately, the coupling of compound 
2.1 to 1-pyrenebutyric acid to yield compound 2.9 proved to be problematic. 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC) coupling, when used with 4-
dimethylaminopyridine (DMAP) and N-methylmorpholine (NMM), produces compound 
2.9 but at a low yield of 20%. It is apparent that further optimization of reaction 
conditions is required. 
 
2.2.3  Binding Studies 
The fluorescence titration of coumarin and NBD-tagged boronic acid donor/ 
acceptor were meant to be completed with various diol-containing guests ranging from 
mannose- to catechol-based diol guests. During initial studies, the most promising 
results were obtained with HEPES buffer near neutral pH, and this was used for the 
binding titrations conducted.  
Titrations were conducted using a fluorimeter to observe any fluctuations in 
fluorescence intensities of the donor and acceptor. We expect to see a gradual 
decrease in the coumarin emission signal and a gradual increase the emission intensity 
of the acceptor NBD molecules upon titration with guests. Compound 2.7 solutions 
prepared in HEPES buffer (5 mM at pH 7.4) were titrated against donor/acceptor 
solution (13.6 μM) and reasonable results were obtained as shown in Figure 2.15. 
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However, it was odd that the emission of NBD increased and then decreased. Thus, it is 




a)   
b)  
c)   
Figure 2.15 FRET-based fluorescence studies 
a) FRET donor–acceptor signal  
b) Decrease in fluorescence signal of Coumarin 













































Tert-Butyl (2-aminoethyl)carbamate (2.1) 
 
Ethane-1,2-diamine (12.0 mL, 179 mmol) was dissolved in dichloromethane (20 mL) 
and stirred. A solution of di-tert-butyldicarbonate (3.91 g, 17.9 mmol) in dichloromethane 
(40 mL) was then added dropwise via an addition funnel. The mixture was stirred 
overnight at room temperature and then extracted with dichloromethane (2 x 50 mL) 
from saturated aqueous sodium carbonate (50 mL). The combined organic layers were 
dried over magnesium sulfate, filtered and concentrated to give the product 2.1 (1.99 g, 
76%) as a yellow oil. Characterization matched prior literature.98 
1H NMR (300 MHz, CDCl3) δ 4.99 (s, 1H), 3.17 (q, J = 5.9 Hz, 2H), 2.80 (t, J = 6.4, 5.5 





(2-(((2-((tert-Butoxycarbonyl)amino)ethyl)amino)methyl)phenyl)boronic acid (2.2) 
 
 
2.1 (0.312 g, 1.95 mmol) and 2-formylphenylboronic acid (0.327 g, 2.14 mmol) are 
added to round bottom flask and the flask was stoppered to have the air removed under 
vacuum. A nitrogen balloon was attached to the flask and the solution was stirred. 
Methanol (25 mL) was then added via a syringe and sodium cyanoborohydride (0.283 g, 
4.28 mmol) was added in methanol via a syringe as well. The solution was then stirred 
overnight at room temperature, and then concentrated. Purification on a reversed-phase 
column (10 g, C18) with gradient elution from 0 to 100% methanol/water gave the 
product as a white solid 2.2 (0.247 g, 43%). 
1H NMR (300 MHz, CD3OD) δ 7.45–7.39 (m, 1H), 7.24–7.11 (m, 3H), 4.05 (s, 2H), 3.39 




2-((2-Boronobenzyl)amino)ethanaminium 2,2,2-trifluoroacetate (2.3) 
  
Trifluoroacetic acid (7 mL) was added to a solution of 2.2 (0.176 g, 0.597 mmol) in 
dichloromethane (7 mL). The reaction mixture was stirred in the dark at room 
temperature for 3 hours and then concentrated and dried under vacuum to obtain a 
yellow solid of trifluoroacetate salts (0.298 g, 162%). The high yield is due to the leftover 
trifluoroacetic acid and will be removed in the next step of the synthesis.  




tert-Butyl (2-(2H-chromene-3-carboxamido)ethyl)carbamate (2.4) 
 
To a stirred solution of compound 2.1 (0.111 g, 0.705 mmol) in dichloromethane (8 mL) 
was added coumarin-3-carboxylic acid (0.1118 g, 0.588 mmol), N-methylmorpholine 
(129 μL, 1.18 mmol) and 4-dimethylaminopyridine (0.0718 g, 0.588 mmol). The solution 
was then cooled to 0 oC and stirred for 15 minutes. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide in hydrochloride (0.135 g, 0.705 mmol) then added at 
0 oC, and the reaction was stirred overnight while warming to room temperature. 
Afterwards, the solution was extracted with dichloromethane (12 mL) and water (20 mL). 
After collecting the organic layer, the aqueous layer was washed again with 
dichloromethane (20 mL). The organic layers were combined and dried with anhydrous 
magnesium sulfate, filtered, and the solvent was removed. Column chromatography 
with silica gel and a solvent gradient of 1%–5% methanol/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
dichloromethane yielded 2.2 (0.124 g, 53%) as a yellow powder.  
1H NMR (300 MHz, CDCl3) δ 9.00 (s, 1H), 8.90 (d, J = 0.7 Hz, 1H), 7.86–7.56 (m, 2H), 
7.55–7.23 (m, 2H), 5.20 (s, 1H), 5.09 (s, 1H), 3.60 (q, J = 3.0 Hz, 2H), 3.40 (q, J = 6.0 
Hz, 2H), 1.44 (s, 9H) ppm. 




2-(((2-(2-Oxo-2H-chromene-3-carboxamido)ethyl)amino)methyl)phenylboronic acid (2.5) 
 
To a stirred solution of compound 2.2 (0.074 g, 0.214 mmol) in dichloromethane (5 mL) 
and acetonitrile (5 mL) was added coumarin-3-carboxylic acid (0.0338 g, 0.178 mmol), 
N-methylmorpholine (39.1 μL, 0.356 mmol) and 4-dimethylaminopyridine (0.0217 g, 
0.178 mmol). The solution was then cooled to 0 oC and stirred for 15 minutes. 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide in hydrochloride (0.0410 g, 0.214 mmol) then 
added at 0 oC, and the reaction was stirred overnight while warming to room 
temperature. Afterwards, the solution was concentrated and then extracted with 
dichloromethane (20 mL) and water (20 mL). After collecting the organic layer, the 
aqueous layer was washed again with dichloromethane (20 mL). The organic layers 
were combined and dried with anhydrous magnesium sulfate, filtered, and the solvent 
was removed. Purification on a reversed-phase column (10 g, C18) with gradient elution 
from 0 to 100% methanol/water gave the product as a yellow solid 2.5 (0.245 g, 38 %). 
1H NMR (300 MHz, CD3OD) δ 8.87 (s, 1H), 7.88–7.80 (m, 1H), 7.80-7.70 (m, 1H) 7.44 




tert-Butyl (2-(4-(pyren-1-yl)butanamido)ethyl)carbamate (2.9) 
 
To a stirred solution of compound 2.1 (0.677 g, 4.23 mmol) in N,N– dimethylformamide 
(5 mL) was added 1-pyrenebutyric acid (0.813 g, 0.282 mmol), N-methylmorpholine 
(0.612 mL, 2.82 mmol) and 4-dimethylaminopyridine (0.344 g, 2.82 mmol). The solution 
was then cooled to 0 oC and stirred for 15 minutes. 1-Ethyl-3-(3 
dimethylaminopropyl)carbodiimide in hydrochloride (0.811 g, 4.23 mmol) was then 
added at 0 oC, and the reaction was stirred overnight while warming to room 
temperature. Afterwards, the solution was concentrated and then extracted with 
dichloromethane (20 mL) and water (20 mL). After collecting the organic layer, the 
aqueous layer was washed again with dichloromethane (20 mL) twice. The organic 
layers were combined and dried with anhydrous magnesium sulfate, filtered, and the 
solvent was removed. Column chromatography with silica gel and a solvent gradient of 
40%–60% ethyl acetate/ hexane yielded 2.9 (0.243 g, 20%) as a yellow powder. 
1H NMR (300 MHz, CDCl3) δ 8.38–8.32 (m, 1H), 8.20–8.08 (m, 4H), 8.04–8.01 (m, 2H), 
7.99 (d, J = 2.1 Hz, 1H), 7.87 (dd, J = 7.8, 3.7 Hz, 1H), 3.58 (p, J = 6 Hz, 2H), 3.45 (d, J 




Chapter 3  Miscellaneous Microarray Analysis and 
Synthetic Compounds 
3.1  Synthesis of N-(4-nitrobenzenesulfonyl) alanine and N-(4-
nitrophenyl) alanine 
For a collaborative project with Dr. Robert Compton, we synthesized N-(4-
nitrobenzenesulfonyl)-L-alanine (3.2a), N-(4-nitrobenzenesulfonyl)-D-alanine (3.2b), N-
(4-nitrophenyl)-L-alanine (3.3a) and N-(4-nitrophenyl)-D-alanine (3.3b) to study their 
circular dichroism (CD) and negative-ion properties.  
 
 







N-(4-nitrobenzenesulfonyl)-L-alanine (3.2a) and N-(4-nitrobenzenesulfonyl)-D-alanine 
(3.2b) To produce compound 3.2a, an aqueous 1 M sodium hydroxide solution (5 mL) 
was added to L-alanine (3.2a, 1.00 g, 11.3 mmol), followed by cooling to 0 °C.  4-
Nitrobenzenesulfonyl chloride (3.82 g, 16.9 mmol) was next added in small portions, 
and the reaction mixture was stirred at rt overnight, followed by washing with ethyl 
acetate (2 × 10 mL). The aqueous layer was then acidified with 1 M hydrochloric acid 
(10 mL) and extracted with ethyl acetate (15 mL). The latter organic layer was dried with 
magnesium sulfate, filtered, and concentrated.  Column chromatography over silica gel 
with gradient elution from 5 to 20% methanol/dichloromethane gave the product as a 
yellow solid (0.71 g, 31%). Enantiomer 3.2b was similarly prepared using D-alanine 
(3.1b, 1.01 g, 11.3 mmol), 1 M sodium hydroxide (7 mL) and 4-nitrobenzenesulfonyl 
chloride (3.82 g, 16.9 mmol), which yielded 3.2b as a light yellow solid ( 0.831 g, 35%).  
1H NMR (300 MHz, DMSO-d6) δ 8.37 (d, J = 7.1 Hz, 2H), 8.04 (d, J = 7.1 Hz, 2H), 3.68 





N-(4-nitrophenyl)-L-alanine (3a) and N-(4-nitrophenyl)-D-alanine (3b) To produce 
compound 3a, 20 mL of N,N-dimethylformamide (DMF) was added to L-alanine (1a, 
0.950 g, 10.7 mmol).  Potassium carbonate (2.95 g, 21.3 mmol) and potassium iodide 
(1.77 g, 10.7 mmol) were then added to the stirring solution. 4-Chloronitrobenzene (3.36 
g, 21.3 mmol) was next added in small portions, and the reaction mixture was stirred 
and refluxed at 120 oC overnight. Next, the solvent was removed via rotary evaporation. 
The crude product was then dissolved in 50 mL of water, acidified with 1 M hydrochloric 
acid (20 mL), and extracted with ethyl acetate (2 x 25 mL). The latter organic layer was 
dried with magnesium sulfate, filtered, and concentrated.  Column chromatography over 
silica gel with gradient elution from 1 to 25% methanol/dichloromethane gave the 
product as a yellow solid (1.21 g, 54%). Enantiomer 3b was similarly prepared using D-
alanine (1b, 0.880 g, 9.90 mmol), 20 mL of DMF, potassium carbonate (2.74 g, 19.8 
mmol), tetrabutylammonium iodide (3.66 g, 9.90 mmol) and 4-chloronitrobenzene 
(3.12g, 19.8 mmol), which yielded 3b as a yellow solid (0.67 g, 32%). 1H NMR (300 MHz, 
Methanol- d4) δ 8.02 (d, J = 9 Hz, 2H), 6.60 (d, J = 9 Hz, 2H), 3.96 (q, J = 9 Hz, 1H), 




3.2  Carbohydrate Microarray Analysis 
 For a collaborative project with Dr. David Baker, we will utilize covalent 
immobilization of thiol-terminated sugars as shown in Figure 3.2 onto epoxide 
functionalized slides. This allows for a very stable glycan microarray for interrogation 
with proteins. This project was previously worked on by Irene Abia from the Baker lab. 
 
Figure 3.2. Thiol-terminated mannose used in binding studies. 
Using robotic printing technology, thiol-terminated mannose derivatives 3.4a, 
3.4b and 3.4c were printed onto epoxide-functionalized glass slides (Figure 3.2) to 




3.2.1  Experimental 
3.2.1.1 Materials 
Epoxide-derivatized glass slides (Nexterion slide E, SCHOTT North America), 
Rhodamine labeled Conconavalin A (Vector Labs), thiol-terminated mannose 
derivatives; all other standard chemicals were purchased from commercial suppliers 
and used as received. Glass slides were stored in a desiccator to keep them dry. 
3.2.1.2. Methods 
Printing sugar solutions were made up of sugar, PBS (30 mM phosphate-
buffered saline and 0.05% Tween-20) of pH 8.5 and TCEP. The final TCEP 
concentration in each prepared sugar solution was 2 mM. On a single glass slide, 12 
different concentrations (0, 25, 50,100, 150, 200, 250, 300, 400, 500, 750, 1000 μM) of 
each sugar were probed with 6 different concentrations of protein Con A (0, 5, 10, 20, 
30, 50 μg/mL, which corresponds to 0, 48, 96, 192, 288 and 481 nM, respectively). 
Using the standard robotic pin printer (Virtek ChipwriterTM Professional Arrayer, Figure 
20), the different solutions of sugars were printed on epoxide functionalized glass slides. 
Each super grid had 3 grids, and each grid was printed in a 12 × 10 pattern. After an 
overnight incubation at room temperature, slides were washed by submerging them in 
Petri dishes filled with wash buffer (PBS, pH 7.4 containing 0.05% Tween-20) and 
gently shaking on a waver for 30 min. To block unreacted epoxides, slides were 
submerged in Petri dishes filled with a block solution (50 mM ethanolamine in 100 mM 
borate, pH 9.2) and gently shaken for 1 h on a waver. After blocking, the slides were 
washed three times by immersing them in Petri dishes filled with PBS buffer (pH 8.4) 
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and dried by gentle purging with N2 air. Slides were immediately used for incubation 
with protein. 
Rhodamine-labeled Con A (5 mg/mL) was diluted in PBS buffer. Six different 
concentrations of Con A were obtained: 2, 5, 10, 20, 30 and 50 μg/mL. An incubation 
chamber was fabricated by placing a damp, warm paper towel in a covered plastic box. 
The IC-16 chamber from Nexterion was used to separate the supergrids. For 
incubations, 120 μL of protein solution was applied to each supergrid, and slides were 
placed in the incubation chamber and placed on the shaker for 1 h at room temperature. 
After incubation, slides were washed three times in Petri dishes filled with wash buffer 
for three times with distilled water, and then dried by gentle purging with N2 air to ensure 
complete dryness. Each wash was approximately 5 min. The dried plates were scanned 
immediately to obtain results. 
3.2.2 Preliminary Results
 
Figure 3.3. Scanned image of glycan microarray with Con A. Monosaccharide 3.4a, 
disaccharide 3.4b, and trisaccharide 3.4c. Protein concentrations: 0 μg/mL 





Preliminary results of microarray analysis proved to be successful as increasing 
fluorescence intensity is observed with increasing protein concentration and glycan 
concentration. Interestingly, the grids incubated with no protein concentration showed 
fluorescence and that should not have been the case. However, work remains to be 
done as this assay requires that perfectly printed supergrids and the slide shown in 
Figure 3.3 has a few grids which were not completed printed. It is necessary that we 
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